Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Agnes Buzin, MDPrincipal Investigator
- Alberto Bosi, MD
Aziendo Osperdaliero Universitaria Careggi Oncologia
Principal Investigator - Aleksander Skotnicki, MD
Katedra i Klinika Hematologii Collegium Medicum
Principal Investigator - Alexander Gaiger, MD
Medical University Hospital
Principal Investigator - Anatoli Golenkov, MD
Head of Clinical Heam and Immunotherapy Dept.
Principal Investigator - Arnaud Pigneux, MD
CHU du Hart Leveque
Principal Investigator - Arnold Ganser, MD
ABT Hamatologie und Onkologie
Principal Investigator - Auro del Giglio, MD
Faculdade de Medicina do ABC
Principal Investigator - Belinda Pinto Simoes, MD
Hospital das Clinicas de Faculdade de Medicina de Ribeirao Preto
Principal Investigator - Bob Lowenberg, MD
Eramus University Medical Centre
Principal Investigator - Bruno Quesnel, MDPrincipal Investigator
- Carlos Sergio Chiattone, MD
Irmandade da Santa Casa de Misercordia de Sao Paulo
Principal Investigator - Carmino Antonio de Souza, MD
Hospital de Clinicias da UICAMP - Centro de Hematologia e Hemoterapia
Principal Investigator - David Barqueti Jendiroba, MD
Centro Goiano de Oncologia
Principal Investigator - David Nachbaur, MD
Department of Heamatology
Principal Investigator - Deiter Niederwieser, MD
Abt. Haematologie / Onkologie
Principal Investigator - Dieter Hoelzer, MD
Leiterin der Studienzentrale
Principal Investigator - Ellen Ritchie, MD
Weill Medical College of Cornell University
Principal Investigator - Enrica Morra, MD
Complessa di Ematologia and Dir Departmento
Principal Investigator - Enrico Pogliani, MD
Ematologia
Principal Investigator - Ernesto de Meis, MD
INCA - Instituto Nacional de Cancer
Principal Investigator - Eugenio Gallo, MD
Divisione di Ematologia
Principal Investigator - Felicetto Ferrara, MD
Azienda Ospedaliera Antonio Cardarelli
Principal Investigator - Fernando Antonio Sellos Ribeiro, MD
Instituto Estadual de Hematologia Artur de Siqueira Cavalcanti - HEMORIO
Principal Investigator - Francesco Turturro, MD
Louisana State University Health Sciences Center
Principal Investigator - Francis Witz, MDPrincipal Investigator
- Francisco Gonzalez, MD
Liberty Hematology and Oncology
Principal Investigator - Francoise Huguet-Rigal, MD
Service d'Hematologie
Principal Investigator - Genadi Iosava, MD
Institute for Heamatology & Transfusiology
Principal Investigator - Gerhard Ehninger, MD
Klinikum Carl Gustav Carus der Technischen Universitat
Principal Investigator - Herve Dombret, MD
Service Clinique des Maladies du Sang
Principal Investigator - Houmedaly Reman, MDPrincipal Investigator
- Ines Guterres, MD
Hospital Nossa Senhora de Conceicao
Principal Investigator - J. Ribera, MD
Insitut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol
Principal Investigator - Jacques Delaunnay, MDPrincipal Investigator
- James Foran, MD
University of Alabama at Birmingham
Principal Investigator - Jerzy Holowiecki, MD
Klinika Hematologii I
Principal Investigator - Johnny Francisco Cordeiro Camargo, MD
Hospital Erasto Gaertner - Liga Paranaense de Combate ao Cancer - CEPEP
Principal Investigator - Jose Salvador Rodrigues Oliveira, MD
Hospital Santa Marcelina
Principal Investigator - K. Abdulkadyrov, MD
Head of Hematology Clinic
Principal Investigator - Karen Seiter, MD
New York Medical College, Division of Oncology
Principal Investigator - Katarzyna Jamieson, MD
University of Florida
Principal Investigator - Kazimierz Kuliczkowski, MD
Department of Heamatology
Principal Investigator - Kellie Sprague, MD
Tufts Medical Center
Principal Investigator - Leonard Heffner, MD
The Emory Clinic
Principal Investigator - Lucia Mariano da Rocha Silla, MD
Hospital de Clinicas de Porto Alegre
Principal Investigator - Luis Isola, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - Madan Jagasia, MD
The Vanderbilt University Medical Center
Principal Investigator - Mair Pedro de Souza, MD
Fundacao Hospital Amaral Carvalho
Principal Investigator - Mamia Zodelava, MD
Heamatology and Transfusiology Dept
Principal Investigator - Maria Aparecida Zanichelli, MD
Hospital Brigadeiro
Principal Investigator - Maria Lucia de Martino Lee, MD
Instituto de Oncologia Pediatrica - GRAACC Grupo de Apoio as Adolescente e a Crianca com Cancer - UNIFESP
Principal Investigator - Mathias Schmid, MD
Innere Medizin III, Hamatologie und Onkologie
Principal Investigator - Matthias Stelljes, MD
Innere Medizin A
Principal Investigator - Meir Wetzler, MD
Roswell Park Cancer Institute
Principal Investigator - Michael Pfreunschuh, MD
Medizinische Klinik I
Principal Investigator - Michele Baccarani, MD
Istitutp di Ematologia ed Oncologia Medica
Principal Investigator - Nicholas Novitzky, MD
Division of Haematology
Principal Investigator - Norbert Ifrah, MDPrincipal Investigator
- Norbert Schmitz, MD
Hamatologsiche Abteilung
Principal Investigator - Norbert Vey, MDPrincipal Investigator
- Peter Staib, MD
Med. Klinik I / Hamatolgie
Principal Investigator - R. Haas, MD
Universitatsklinik Dusseldorf
Principal Investigator - Reinhard Andreesen, MD
Universitat Regensburg
Principal Investigator - Renato Bassan, MD
Dipartimento di Oncoloia ed Ematico
Principal Investigator - Ricardo Pasquini, MD
Hospital de Clinicas da Universidade Federal do Parana
Principal Investigator - Roberto Foa, MD
Cattedra di Ematologie
Principal Investigator - S. Moiseev, MD
Faculty Therapy Dept
Principal Investigator - Salvatore Mirto, MD
Azienda Osperdaliera Vincenzo Cervello Divisione
Principal Investigator - Stephane de Botton, MDPrincipal Investigator
- Tadeusz Robak, MD
Klinika Hematologii Akademii Meduycznej Wojewodzki
Principal Investigator - Tanya Trippett, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator - Ulrich Duehrsen, MDPrincipal Investigator
- Valerie Savchenko, MD
Dir. Research Institute for BMT and Molecular Hematology
Principal Investigator - Vernon Louw, MD
Free State University
Principal Investigator - Vincenzo Liso, MD
UO Universita degi Studi Policinico Ematologia
Principal Investigator - W-D Ludwig, MD
Charite Universitatsmedizin Berlin
Principal Investigator - Walter Aulitzky, MD
Innere Abt. II
Principal Investigator - Wendy Stock, MD
University of Chicago Hospital
Principal Investigator - Werner Linkersch, MD
Department of Heamtology
Principal Investigator - Wieslaw Jedrzejczak, MD
Klinika Hematologii i Onkologii
Principal Investigator - Xavier Thomas, MD
Maladies du Sang
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Chicago Medical Center
Chicago, Illinois, United States
- Louisana State University Health Sciences Center
Shreveport, Louisiana, United States
- New York Medical College Division of Oncology
Valhalla, New York, United States
- Liberty Hematology and Oncology
Columbia, South Carolina, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2006
- Primary completion
- 31 Mar 2007
- Completion
- 31 Mar 2007
- Last update posted
- 23 Jan 2012
- Registered enrollment
- 100
- Registry id
- NCT00419081
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.